EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Salivary polyreactive and SARS-CoV-2-specific antibody responses following SARS-CoV-2 infection and vaccination in healthcare workers

Mischa H Koenen, Juana Claus, Myrthe E Reiche, Geert H van Weelden, Annemijn Arns, Christa E van der Gaast-de Jongh, Manon Kolkman, Thijs Ten Doesschate, Helen L Leavis, Janneke H H M van de Wijgert, Marien I de Jonge, Lilly M Verhagen

Clinical Immunology · 2026-10 · 287 · 110756

DOI: 10.1016/j.clim.2026.110756 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Immunology, 2026-10. Verfasst von Mischa H Koenen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Sophia Children's Hospital, Erasmus Medical Centre, Rotterdam, the Netherlands; Department of Paediatrics, Elisabeth-Twees…. Hauptthemen laut MEDLINE: Antibodies, Viral, Saliva, SARS-CoV-2, Health Personnel. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Radboud University Medical Center, Netherlands Organisation for Health Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mucosal immunity constitutes the first line of defense against respiratory viruses. We characterized serum and salivary SARS-CoV-2-specific and polyreactive antibodies in 784 Dutch healthcare workers at two timepoints (2020-2021). SARS-CoV-2-specific antibodies and salivary polyreactive IgA were quantified using multiplex immunoassays. Associations with infection, vaccination, and symptom burden were analyzed using multivariable regression, Cox proportional hazard models, and mixed-effects models. SARS-CoV-2 infection induced systemic SARS-CoV-2-specific IgG and salivary IgA responses, whereas vaccination increased serum and salivary anti-Spike-1 IgG. Salivary polyreactive IgA increased over time, was associated with smoking (p = 0.022) and asthma (p = 0.021), and higher levels were associated with an increased hazard of subsequent SARS-CoV-2 infection (HR 1.15 [1.01-1.31]). Polyreactive IgA levels declined more rapidly in participants with a higher symptom burden (p = 0.081). SARS-CoV-2 infection, but not vaccination, induces distinct changes in the salivary IgA compartment. Salivary polyreactive IgA levels changed over time, which may reflect repeated mucosal immune stimulation, and were associated with greater symptom burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, ViralSalivaSARS-CoV-2Health PersonnelCOVID-19COVID-19 VaccinesHumansMaleFemaleAdultMiddle AgedImmunoglobulin GVaccinationImmunoglobulin AImmunoglobulin A, SecretoryImmunity, MucosalAntibody FormationSpike Glycoprotein, Coronavirus

Stichwörter der Autor:innen

AntibodiesImmunoglobulin AMucosalPolyreactiveSARS-CoV-2Saliva

Substanzen

Antibodies, ViralImmunoglobulin GImmunoglobulin ACOVID-19 VaccinesImmunoglobulin A, SecretorySpike Glycoprotein, Coronavirus

Autor:innen und Institutionen

  • Department of Paediatrics, Sophia Children's Hospital, Erasmus Medical Centre, Rotterdam, the Netherlands; Department of Paediatrics, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands.
  • Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Department of Laboratory Medicine, Laboratory of Medical Immunology, Radboud Community for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands; Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherla…
  • Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Department of Laboratory Medicine, Laboratory of Medical Immunology, Radboud Community for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Paediatric Infectious Diseases…

Förderung

  • Radboud University Medical Center
  • Netherlands Organisation for Health Research and Development

Zitieren

APA

Koenen, M. H., Claus, J., Reiche, M. E., van Weelden, G. H., Arns, A., van der Gaast-de Jongh, C. E., Kolkman, M., Ten Doesschate, T., Leavis, H. L., van de Wijgert, J. H. H. M., de Jonge, M. I., & Verhagen, L. M. (2026). Salivary polyreactive and SARS-CoV-2-specific antibody responses following SARS-CoV-2 infection and vaccination in healthcare workers. Clinical Immunology, 287, 110756. https://doi.org/10.1016/j.clim.2026.110756

Vancouver

Koenen MH, Claus J, Reiche ME, van Weelden GH, Arns A, van der Gaast-de Jongh CE, et al. Salivary polyreactive and SARS-CoV-2-specific antibody responses following SARS-CoV-2 infection and vaccination in healthcare workers. Clinical Immunology. 2026;287:110756. doi:10.1016/j.clim.2026.110756

BibTeX
@article{Koenen2026,
  author = {Koenen, Mischa H and Claus, Juana and Reiche, Myrthe E and van Weelden, Geert H and Arns, Annemijn and van der Gaast-de Jongh, Christa E and Kolkman, Manon and Ten Doesschate, Thijs and Leavis, Helen L and van de Wijgert, Janneke H H M and de Jonge, Marien I and Verhagen, Lilly M},
  title = {Salivary polyreactive and SARS-CoV-2-specific antibody responses following SARS-CoV-2 infection and vaccination in healthcare workers},
  journal = {Clinical Immunology},
  year = {2026},
  volume = {287},
  pages = {110756},
  doi = {10.1016/j.clim.2026.110756}
}
Kostenlos starten →